A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Japanese Healthy Men.

Trial Profile

A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Japanese Healthy Men.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 May 2009

At a glance

  • Drugs AZD 3199; AZD 3199
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 06 May 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov
    • 06 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 17 Nov 2008 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top